Literature DB >> 19137789

Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis.

Ewa Orlowska-Baranowska1, Rafal Baranowski, Lidia Greszata, Janina Stepinska.   

Abstract

BACKGROUND AND AIM OF THE STUDY: In aortic stenosis (AS), serum levels of brain natriuretic peptide (BNP) are elevated, but the relation of this elevation to the degree of left ventricular hypertrophy (LVH) remains unclear. The study aim was to assess the relationship between BNP and LVH (expressed as LV mass index, LVMI) and LV wall thickness index (WThI) in a group of patients.
METHODS: A total of 147 patients with AS (85 men, 62 women; mean age 61 +/- 12 years) each underwent echocardiography and serum BNP analysis. The correlation between serum BNP level and LVH was investigated, with patient gender, age, NYHA class, AS severity and presence of coronary artery disease also being taken into account.
RESULTS: Among AS patients, serum BNP levels ranged from 3 to 2010 pg/ml; mean BNP levels were similar in women and men (213 +/- 302 and 253 +/- 375 pg/ml, respectively). The BNP level also correlated directly with the LVMI (r = 0.55; p <0.0001), WThI (r = 0.26; p <0.001), end-diastolic dimension (r = 0.43; p <0.0001), mean aortic gradient (r = 0.25; p = 0.002), age (r = 0.27; p = 0.001); and correlated inversely with the LV ejection fraction (r = -0.52; p <0.0001). Eccentric LVH was associated with a significantly higher serum BNP level (506 +/- 558 pg/ml) than concentric-type hypertrophy (190 +/- 254 pg/ml; p = 0.002).
CONCLUSION: The measurement of serum BNP levels is of potential value when monitoring LVH in aortic stenosis patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19137789

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  6 in total

1.  Validation of plasma biomarkers in degenerative calcific aortic stenosis.

Authors:  Giovanni Ferrari; Rachana Sainger; Erik Beckmann; Gianluca Keller; Pey-Jen Yu; Maria Cristina Monti; Aubrey C Galloway; Richard L Weiss; William Vernick; Juan B Grau
Journal:  J Surg Res       Date:  2010-05-06       Impact factor: 2.192

2.  N-terminal pro-B-type natriuretic peptide measurement is useful in predicting left ventricular hypertrophy regression after aortic valve replacement in patients with severe aortic stenosis.

Authors:  Mirae Lee; Jin-Oh Choi; Sung-Ji Park; Eun Young Kim; PyoWon Park; Jae K Oh; Eun-Seok Jeon
Journal:  Heart Asia       Date:  2015-04-27

3.  Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement.

Authors:  Roman Pfister; Thorsten Wahlers; Frank M Baer; Max Scherner; Justus Strauch; Erland Erdmann
Journal:  Clin Res Cardiol       Date:  2010-02-06       Impact factor: 5.460

4.  Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease.

Authors:  Rachana Sainger; Juan B Grau; Emanuela Branchetti; Paolo Poggio; Eric Lai; Erblina Koka; William J Vernick; Robert C Gorman; Joseph E Bavaria; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2013-03

5.  B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.

Authors:  Kimi Sato; Arnav Kumar; Amar Krishnaswamy; Stephanie Mick; Milind Y Desai; Brian P Griffin; Samir R Kapadia; Zoran B Popović
Journal:  Clin Cardiol       Date:  2018-12-31       Impact factor: 2.882

6.  Direct Actions of AT1 (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy.

Authors:  Matthew A Sparks; Fitra Rianto; Edward Diaz; Ritika Revoori; Thien Hoang; Lucas Bouknight; Johannes Stegbauer; Anuradha Vivekanandan-Giri; Phillip Ruiz; Subramaniam Pennathur; Dennis M Abraham; Susan B Gurley; Steven D Crowley; Thomas M Coffman
Journal:  Hypertension       Date:  2021-01-04       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.